Influence of hepatic impairment on the pharmacokineticsand pharmacodynamics of the P2Y12 receptor antagonist selatogrel


First published in Clinical and Translational Science on 2022 Aug.
Clin Transl Sci. 2022 Aug;15(8):1906-1915. doi: 10.1111/cts.13298. Epub 2022 May 18

Authors: Schilling U, Hsin CH, Delahaye S, Krause A, Wuelfrath H, Halabi A, Dingemanse J.





Read more

Download full article as Pdf file:

Pdf File